Detailed answers about MEREO BIOPHARMA 4 LIMITED, including incorporation, status, business activity, and accounts information.
When was MEREO BIOPHARMA 4 LIMITED founded?
MEREO BIOPHARMA 4 LIMITED was officially incorporated on 24 October 2017 and is registered under company number 11029583. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is MEREO BIOPHARMA 4 LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of MEREO BIOPHARMA 4 LIMITED?
MEREO BIOPHARMA 4 LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does MEREO BIOPHARMA 4 LIMITED do?
MEREO BIOPHARMA 4 LIMITED operates in the following sector: 72110 - Research and experimental development on biotechnology. This provides insight into the company's primary business activity and industry focus.
What is MEREO BIOPHARMA 4 LIMITED's registered address?
The registered office address of MEREO BIOPHARMA 4 LIMITED is 4TH FLOOR, ONE, CAVENDISH PLACE, LONDON, UNITED KINGDOM, W1G 0QF. This is the official address filed with Companies House for legal and statutory correspondence.
Is MEREO BIOPHARMA 4 LIMITED financially stable?
The most recent accounts for MEREO BIOPHARMA 4 LIMITED were made up to 31 December 2024, filed as SMALL. Next accounts are due by 30 September 2026.
Does MEREO BIOPHARMA 4 LIMITED have any charges or mortgages?
MEREO BIOPHARMA 4 LIMITED has 2 registered charges, of which 0 are outstanding, 2 satisfied, and 0 part satisfied. Charges are typically registered when a company uses its assets as security for borrowing.